by Joseph H. Senesac, Frank Flagge, and Shawn Gallagher
Volume 1, Issue 1 (March 2002)
Introgen Therapeutics has been producing clinical-grade adenoviral vectors in scaled-up processes, in cGMP facilities, for over five years. Semi-automated hand filling, using a Watson-Marlow 505Di/L pump, has been used over this period to fill batch sizes of up to 2 liters of adenovirus. While this procedure has been robust and demonstrated a high level of sterility assurance through regularly scheduled media fill studies and product testing, the firm needed to move to the next level of fill sizes. Anticipating up to 10,000 fills in 3 mL vials, Introgen has worked in collaboration with M&O Perry Corp. to develop an automated fill capability that utilizes the same base procedure but in an automated fashion…
Citation:
Senesac JH, Flagge F, Gallagher S. Development of Capabilities for Small-Scale Virus Fills. BioProcess J, 2002; 1(1): 38-42.